跳至主要内容

Liquid Chromatography-Mass Spectrometry in Metabolomics: Identification and Quantification of Metabolites

The field of metabolomics, particularly the identification and quantification of metabolites, has been greatly expedited by advancements in liquid chromatography-mass spectrometry (LC-MS) technology. LC-MS combines the physical separation properties of liquid chromatography with the mass analysis capabilities of mass spectrometry, thus rendering an unparalleled potential for accurate profiling of metabolites in biological samples.

The power of metabolomics lies in its ability to survey the complete set of metabolites or the metabolome in biological systems. However, the extensive diversity of the metabolome, characterized by wide-ranging physicochemical properties, presents a formidable challenge for any single analytical methodology. That’s where LC-MS comes into play.

In LC-MS, liquid chromatography separates complex biological samples into individual metabolite components, while mass spectrometry provides exact mass measurements facilitating the identification and quantification of each compound. Paired together, these two methodologies enable comprehensive and high-resolution metabolomic analyses.

The LC-MS workflow starts with meticulous sample preparation, where metabolites are extracted and purified from the biological samples. Upon successful extraction, the metabolites are resolved using the liquid chromatography column, followed by their detection and mass analysis through the mass spectrometer.


One key advantage of LC-MS in metabolomics is its ability to provide both molecular weight data and structural information about metabolites, supporting accurate identification and quantification. The integration of MS with LC can also provide the sensitivity necessary for detecting metabolites present at very low concentrations.

While data generated from LC-MS is complex, advancements in data processing software and bioinformatics tools have made deciphering and analyzing this information more manageable and accessible. By visualizing and interpreting LC-MS generated data, we can get a deeper understanding of metabolic pathways and mechanisms in various biological systems.

In conclusion, LC-MS, as an indispensable tool in metabolomics, has opened up new avenues for exploring the wonders of the metabolome and advancing our understanding of how biomolecules interact and operate within biological systems. Its powerful capabilities in metabolite separation, identification, and quantification have provided tremendous opportunities in advancing research in various fields including biomedical, environmental, and agricultural science.

The MetID team of Medicilon is composed of experienced scientists. We provide fast and reliable in vivo and in vitro MetID and reactive metabolite capture services. We also support new drug screening and domestic and oversees IND filings. Since the establishment of MetID team, Medicilon has successfully completed multiple different types of research projects for clients, including challenging peptide MetID research.
标签：

评论

发表评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...
发表评论
阅读全文

The Launch Meeting was Held by Medicilon and DAC Biotech of the Contract Research on ADC Preclinical Study

  Chuansha, Shanghai, Nov. 8th, 2019 — Medicilon held the launch meeting with Hangzhou DAC Biotech Co., Ltd to initiate the   preclinical study   of the antibody-drug-conjugate (ADC)  DXC005, including the   pharmacology study ,   DMPK study   and the   safety evaluation . Medicilon has previously completed integrated  preclinical research  on ADC drugs cooperating with DAC Biotech and other companies. Two of them has been approved by NMPA and entered Phase I clinical trials. About Hangzhou DAC Biotech Co., Ltd Hangzhou DAC Biotech, Co., Ltd was officially registered in HEDA Area, Hangzhou City, Zhejiang Province, China around the end of Year 2012, and is located nearby the bank of beautiful Qiantang River. The company focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drug, both of which are banded together with smart linkers. About Antibody-Drug-Conjugate (ADC) ADCs ...
发表评论
阅读全文

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...
发表评论
阅读全文